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PEchocardiography
ndependent and Incremental
rognostic Value of Early Mitral
nnulus Velocity in Patients With
mpaired Left Ventricular Systolic Function
ei Wang, MD, PHD, Gabriel Yip, MD, Cheuk-Man Yu, MD, FRACP, FRCP, Qing Zhang, MD,
an Zhang, MD, Deko Tse, EN, Shun-Ling Kong, RN, John E. Sanderson, MD, FRCP, FACC
ong Kong SAR, China
OBJECTIVES This study sought to investigate the incremental prognostic value of non-invasive measures of
early myocardial relaxation and left ventricular diastolic pressure (LVDP) in patients with
impaired left ventricular (LV) systolic function.
BACKGROUND The early diastolic mitral annulus velocity (Em) reflects myocardial relaxation, and the
combined ratio of the early transmitral flow velocity (E) to Em (E/Em) 15 correlates well
with elevated mean LVDP. It is unknown if these new indexes will predict poorer survival in
patients with LV systolic dysfunction.
METHODS Echocardiograms were prospectively obtained in 182 patients with impaired LV systolic
function, defined as an LV ejection fraction0.50. The end point was cardiac mortality. The
majority of this patient sample (80%) has been reported on in a previous publication.
RESULTS After a median 48 months’ follow-up, Em emerged as an independent predictor of survival
(hazard ratio 0.61, 95% confidence interval 0.45 to 0.82). An Em 3 cm/s was associated
with a significantly excess mortality (log-rank statistic 9.36, p 0.002), and this measurement
added incremental prognostic value to standard indexes of systolic or diastolic function,
including a deceleration time 140 ms and an E/Em 15 (p  0.038).
CONCLUSIONS Early diastolic mitral annulus velocity is a powerful predictor of cardiac mortality in patients
with LV systolic impairment; Em 3 cm/s emerged as the best prognosticator in long-term
follow-up, incremental to other clinical or echocardiographic variables, including the ratio
E/Em. (J Am Coll Cardiol 2005;45:272–7) © 2005 by the American College of Cardiology
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.09.059Foundation
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sn the past decade, various echocardiographic indexes have
een used to predict prognosis in patients with left ventric-
lar (LV) dysfunction and chronic heart failure, including
V dimensions, ejection fraction, and Doppler mitral inflow
elocities (1–4). In particular, the deceleration time (DT) of
arly transmitral flow is the simplest echocardiographic
iastolic parameter that independently predicts poor prog-
osis (4–6) and appears to correlate with LV filling pressure
n patients with systolic dysfunction (7).
Using tissue Doppler imaging (TDI), myocardial veloc-
ties at the mitral annulus have been shown to be useful for
uantifying global systolic and diastolic LV function (8).
he early diastolic myocardial velocity (Em), in particular,
eflects myocardial relaxation and is relatively load-
ndependent (9). In addition, the ratio of early transmitral
ow velocity (E) to early diastolic septal mitral annulus
elocity (E/Em) correlates well with mean LV diastolic
ressure (10) and has recently been shown to be a powerful
ndependent predictor of all-cause mortality after acute
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004, accepted September 29, 2004.yocardial infarction (11). In a previous study, we found
hat an Em value 3 cm/s provides incremental prognostic
alue for predicting cardiac mortality in patients with a
ariety of cardiovascular diseases (12). However, it is uncer-
ain if Em alone has prognostic value in patients with
ystolic dysfunction or if the ratio E/Em is superior. To test
his hypothesis, we evaluated the prognostic value of Em in
large series of unselected patients with impaired LV
ystolic function and compared this with other established
linical, systolic, and diastolic parameters, including the
atio E/Em.
ETHODS
ubjects. The study population consisted of 182 consecutive
ardiovascular patients who had a clinically indicated transtho-
acic echocardiogram that showed impaired systolic function
ith a left ventricular ejection fraction (LVEF) 50% by
wo-dimensional echocardiography using Simpson’s method
range 12.12% to 49.98%, 57% patients with LVEF 40%;
3% with LVEF 40% to 50%). Patients with aortic or mitral
tenosis, prosthetic valves, or severe mitral annular calcification
ere excluded.
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January 18, 2005:272–7 Tissue Doppler Imaging and Prognosischocardiography. Echocardiograms were obtained using
eneral Electric VingMed Sound AB (Horten, Norway)
ith a 3.5-MHz transducer. Methods of acquiring two-
imensional Doppler, TDI, and their measurements were as
reviously described (12). All recordings were performed by
ne investigator (M.W.). Left atrial maximal volume
LAVmax) was traced at the end of systole from apical four-
nd two-chamber views. Abnormal diastolic function was
ategorized into abnormal relaxation filling pattern, pseudo-
ormal filling pattern, and restrictive filling pattern accord-
ng to Garcia et al. (13). We used average value of
yocardial velocities measured at septal, lateral, inferior,
nd anterior aspect as previously described. Peak velocities
uring systole (Sm), early diastole (Em), and late diastole
Am) were measured.
utcome measurements. Death and mode of death were
dentified from hospital records or telephone interviews
ith relatives. Cardiac death was defined as death caused by
eart disease, including sudden death.
tatistics analysis. Continuous data are expressed as mean
alues  SD, and comparisons between groups were tested
y unpaired t test. Categorical data are presented as absolute
alues and percentages, and comparisons were tested by
isher exact test. Estimations of risk were performed using
ox proportional hazard models by univariate and multi-
ariate analysis. Patients who died from other causes or were
ost to follow-up were censored.
Abbreviations and Acronyms
Am  late diastolic mitral annular velocity
DT  mitral deceleration time
E  early diastolic transmitral flow velocity
Em  early diastolic mitral annular velocity
LAVmax  left atrial volume at the end of left
ventricular systole
LV  left ventricle/ventricular
LVEF  left ventricular ejection fraction
Sm  systolic mitral annular velocity
TDI  tissue Doppler imaging
Table 1. Clinical Characteristics
All Patients
(n  182)
Age (yrs) 63  15
Male gender 124 (68%)
Ischemic heart disease 69 (38%)
Myocardial infarction 42 (23%)
Hypertension 92 (51%)
Hyperlipidemia 24 (13%)
Valvular heart disease 27 (15%)
Dilated cardiomyopathy 29 (16%)
Heart failure 119 (65%)
Diabetes mellitus 64 (35%)
Cerebral vascular accidents or
peripheral vascular disease
16 (9%)
Chronic renal failure 43 (24%)
Obstructive sleep apnea 21 (12%)Em  early diastolic mitral annular velocity.The incremental value of TDI over clinical data and
ransmitral inflow variables was assessed in four modeling
teps in the same order as in clinical practice. The first step
onsisted of clinical data used as baseline risk factors.
ransmitral inflow variable was then added in the next
lock. The third block was E/Em 15. In the final step,
DI variables were added. A significant improvement in
odel prediction was based on the likelihood ratio statistic,
hich follows a chi-square distribution, and the p value was
ased on the incremental value compared with the previous
odel.
Cumulative survival curve was performed by Kaplan-
eier method, and mortality rates were compared using the
og-rank test. SPSS version 11.5 (SPSS Inc., Chicago,
llinois) was used for all analyses.
ESULTS
he study population consisted of 124 male (68%) and 58
emale (32%) patients with a mean age of 63  15 years.
hese patients had high prevalence of hypertension, a
istory of ischemic heart disease and/or diabetes mellitus,
nd were more likely to present with clinical evidence of LV
eart failure (Table 1). Two patients had atrial fibrillation.
he echocardiographic characteristics of those patients with
m 3 and Em 3 cm/s are shown in Table 2.
Sixty-nine patients (38%) had Em 3. These patients
ere older and more often had a history of ischemic heart
isease than those with Em 3. Patients with Em 3 had
orse LVEF, lower E, reduced Sm, and higher E/Em. In
ddition, of those with Em 3, 94% had an E/Em 15.
owever, there was no difference in LAVmax and the
revalence of moderate or severe mitral regurgitation be-
ween the two groups.
redictors and outcome. All patients were followed for a
edian of 48 months (range 0.3 to 68 months); 36 patients
20%) died of a cardiac cause. A history of ischemic heart
isease, valvular heart disease, or heart failure were the most
ommon baseline diagnoses in those who died (Table 3). In
Em >3
(n  113)
Em <3
(n  69) p Value
60  15 67  13 0.001
80 (71%) 44 (64%) 0.33
36 (32%) 33 (48%) 0.04
22 (20%) 20 (29%) 0.15
55 (49%) 37 (54%) 0.54
17 (15%) 7 (10%) 0.38
17 (15%) 10 (15%) 1.00
18 (16%) 11 (16%) 1.00
69 (61%) 50 (73%) 0.15
43 (38%) 21 (30%) 0.34
6 (5%) 10 (15%) 0.06
24 (21%) 19 (28%) 0.37
15 (13%) 6 (9%) 0.47
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Tissue Doppler Imaging and Prognosis January 18, 2005:272–7ddition, 12 patients died due to other causes such as
acterial septicemia, cancer, or unknown.
The majority of cardiac deaths (22 of 36 [61%])
ccurred in patients with Em 3. Figure 1 shows the
ncreased mortality associated with Em 3 (log-rank 
.36, p  0.002). Similar analyses were performed after
tratifying patients on the basis of their DT; Em 3 was
strong predictor of cardiac mortality in patients with a
T 140 ms (n  132, log-rank  7.20, p  0.007). In
atients with DT 140 ms, the prognostic utility of an
m 3 did not attain statistical significance (n  44,
og-rank  1.48, p  0.22), which was likely due to the
nsufficient numbers of events. However, there was a
rend showing more patients with Em 3 died after
ne-year of follow-up. When patients were stratified on
he basis of their E/Em, Em 3 still predicted increased
ardiac mortality even in patients with an E/Em 15 (n
141, log-rank  5.15, p  0.02). Of 32 patients with
n E/Em 15, only one patient died who had an Em 3.
hus, the combination of an E/Em 15 and Em 3
m/s predicted a more favorable outcome.
The association between the clinical and echocardio-
Table 2. Echocardiographic Variable Characte
All Patients
(n  182)
M-Mode and 2-D
IVSd (cm) 1.3  0.4
LVPWd (cm) 1.3  0.3
LVDd (cm) 5.8  1.2
LVDs (cm) 4.5 1.3
LV mass (g) 396  133
FS (%) 21  10
LVEF (%) 36 9
LAEF (%) 42 14
LAVmax (ml) 70 25
Mitral inflow velocities
E (cm/s) 79 27
A (cm/s) 72 28
DT (ms)* 189 67
DT 140 ms 44 (25%)
DT 140 ms 132 (75%)
E/A 1.4  0.9
Tissue Doppler imaging
Sm (cm/s) 3.4 1.3
Em (cm/s) 3.6 1.6
Am (cm/s) 5.0 2.3
E/Am 0.9  0.9
LV diastolic filling pressure
E/Em† 27 16
E/Em 15 31 (18%)
E/Em 15 141 (82%)
Moderate or severe MR 24 (13%)
*Deceleration time could be assessed in 176 patients (97%);
A  late transmitral flow velocity; Am  late diastolic m
diastolic transmitral flow velocity; Em  early diastolic mit
velocity; E/Am  ratio of early to late peak mitral annular v
wall thickness in end-diastole; LAEF  left atrial ejection fr
systole; LV left ventricular; LVDd left ventricular end-di
LVEF  left ventricular ejection fraction; LVPWd  left v
regurgitation; Sm  systolic mitral annular velocity; 2-D raphic variables and the end point was assessed by univar- rate analysis as shown in Table 3. Clinical risk factors such
s age, ischemic heart disease, valvular heart disease, and
eart failure were associated with an adverse outcome.
ystolic mitral annular velocity, Em, Am, E/Em, and DT
140 were associated with cardiac death. In multivariate
ox regression, backward stepwise analysis adjusted by age,
m, Em, Am, E/Em, and DT, Em remained the strongest
redictor for cardiac death (0.61, 95% confidence interval:
.45 to 0.82).
The incremental value of an Em 3 is shown in Figure
; E/Em 15 improved the prognostic value of a model
ontaining clinical risk factors and DT 140 (p  0.05).
owever, Em 3 significantly improved the outcome of a
ode that contained clinical risk factors, DT 140 and
/Em 15 (p  0.038).
edication and outcome. At baseline, there was no dif-
erence in the use of angiotensin-converting enzyme inhib-
tors/angiotensin II antagonists (63% vs. 59%, p  0.62),
alcium-channel blockade (21% vs. 27%, p  0.45), diuret-
cs (57% vs. 52%, p  0.63), and statin therapy (27% vs.
2%, p  0.46) in patients with an Em 3 and 3,
espectively. In contrast, patients with Em 3 tended to
Em >3
(n  113)
Em <3
(n  69) p Value
1.4  0.4 1.3 0.4 0.25
1.2  0.3 1.3 0.3 0.75
5.8  1.2 5.9 1.1 0.42
4.5  1.4 4.6 1.3 0.68
399  140 391 122 0.71
22  9 19 10 0.06
38  8 33 10  0.0005
42  15 40 13 0.45
72  27 65 21 0.10
84  26 72 28 0.004
70  29 74 27 0.32
182  65 199 71 0.13
29 (27%) 15 (22%) 0.75
80 (73%) 52 (78%) 0.12
1.5  0.9 1.2 0.8 0.03
3.8  1.3 2.8 1.0  0.0005
4.4  1.5 2.2 0.6  0.0005
5.0  2.4 4.9 2.1 0.67
1.2  1.0 0.6 0.4  0.0005
20  8 37 21  0.0005
28 (26%) 4 (6%) 0.05
78 (74%) 63 (94%)  0.0005
18 (16%) 6 (9%) 0.18
could be calculated in 172 patients (95%).
annual velocity; DT  mitral deceleration time; E  early
ular velocity; E/A  ratio of early to late transmitral flow
; FS  fractional shortening; IVSd  interventricular septal
; LAVmax  left atrial volume at the end of left ventricular
dimension; LVDs left ventricular end-systolic dimension;
ular posterior wall thickness in end-diastole; MR  mitral
imensional.ristics
†E/Em
itral
ral ann
elocity
action
astoliceceive more aspirin (67% vs. 49%, p  0.03) and beta-
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January 18, 2005:272–7 Tissue Doppler Imaging and Prognosislockers (52% vs. 36%, p  0.05). In our study group,
edication was not predictive of subsequent mortality.
ISCUSSION
he principal finding of the current study was that Em was an
ndependent powerful predictor of survival in patients with
mpaired LV systolic function (LVEF50%). The addition of
m 3 cm/s further improved the prognostic utility of a
odel that included DT 140 ms and E/Em 15.
V filling pressure and prognosis. Elevated LV filling
ressure is associated with increased mortality in dilated
ardiomyopathy (3,14) and after acute myocardial infarction
15,16). A short DT correlates well with elevated left atrial
ressure, especially in patients with impaired LV systolic
unction (7,10) and is an independent predictor of adverse
utcome in patients with acute myocardial infarction (17).
ur study reaffirms the prognostic value of a short DT in
Table 3. Univariate Predictors of Cardiac Deat
Survivors
(n  146)
Clinical risk factors
Age (yrs) 62 15
Male gender 100 (68.5%)
Heart rate (beats/min) 78 16
Ischemic heart disease 48 (33%)
Hypertension 73 (50%)
Valvular heart disease 18 (12%)
Dilated cardiomyopathy 28 (19%)
Heart failure 88 (60%)
Diabetes mellitus 49 (34%)
Hyperlipdemia 18 (12%)
Obstructive sleep apnea 19 (13%)
Moderate to severe MR 18 (12%)
M-mode and 2-D
IVSd (cm) 1.3 0.4
LVDd (cm) 5.8 1.2
FS (%) 21 10
LVEF (%) 37 10
LAEF (%) 43 15
LAV max (ml) 70 25
Mitral inflow velocities
E (m/s) 0.78 0.26
A (m/s) 0.71 0.29
DT 140 ms 32 (22%)
DT 140 ms 111 (78%)
Tissue Doppler imaging
Sm (cm/s) 3.5 1.3
Em cm/s 3.8  1.7
Em 3 cm/s 47 (32%)
Em 3 cm/s 99 (68%)
Am (cm/s) 5.2 2.3
Diastolic filling pressure
E/Em 25 15
E/Em 15 110 (78%)
Diastolic filling patterns
ARP 65 (46%)
PN or RFP 68 (48%)
ARP  abnormal relaxation pattern in diastole; PN  pseud
diastole; other abbreviations as in Table 2.atients with subnormal LVEF. encremental value of E/Em. However, an elevated E/Em
s a more powerful prognostic indicator than transmitral
ow variables. Our calculated E/Em appears to be higher
han previously reported. In our study, Em was a mean value
aken from four different LV annular sites and was mea-
ured after post-processing of the color Doppler data that
ontained mean velocities. This is in contrast with the
elocities recorded by pulsed Doppler where peak instanta-
eous velocities are measured in the sample volume and are
sually recorded only at the septal mitral annulus. The
ff-line values are generally about 15% to 20% lower than
hose obtained by pulsed Doppler (18) and would explain
hy the ratio E/Em is higher.
ncremental value of Em. The current study shows that,
fter a median follow-up of 48 months, Em gradually emerged
s the best predictor of cardiac survival with Em 3 cm/s
dding incremental prognostic data to clinical and standard
Deceased
(n  36)
Hazard Ratio
(95% Confidence Interval)
68  13 1.03 (1.00–1.06)
24 (66.7%) —
80  17 —
21 (58%) 2.36 (1.21–4.61)
19 (53%) —
9 (25%) 2.25 (1.05–4.82)
1 (3%) —
31 (86%) 3.62 (1.41–9.31)
15 (42%) —
6 (17%) —
2 (6%) —
6 (17%) —
1.4  0.4 —
5.8  0.8 —
21  10 —
34  9 —
37  12 —
70  28 —
0.85  0.33 —
0.73  0.26 —
12 (36%) 1.97 (0.97–4.02)
21 (64%) 0.51 (0.25–1.03)
2.9  1.0 0.66 (0.49–0.89)
2.8  1.1 0.66 (0.50–0.86)
22 (61%) 2.72 (1.39–5.33)
14 (39%) 0.37 (0.19–0.72)
4.1  1.9 0.81 (0.69–0.96)
36  18 1.03 (1.01–1.04)
31 (97%) 8.43 (1.15–61.9)
14 (39%) —
21 (58%) —
al mitral inflow pattern; RFP  restrictive filling pattern inhchocardiographic parameters. This long-term study further
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Tissue Doppler Imaging and Prognosis January 18, 2005:272–7upports our previous work in a more general group of cardiac
atients that Em, among other TDI variables, was the stron-
est predictor of cardiac mortality (12); Em correlates closely
ith the time constant of isovolumic relaxation (tau) and is
elatively insensitive to preload changes in the presence of LV
ystolic dysfunction (9), and this may explain why Em is a good
ndicator of function and outcome. Furthermore, abnormalities
f diastolic function are often more sensitive indicators of
verall ventricular function (19). Therefore, measurements of
/Em and Em should be routinely performed in patients with
educed LV systolic function, not merely for estimating the LV
lling pressure and the degree of impairment of myocardial
elaxation but, more importantly, for assessing prognosis and
isk stratification.
igure 1. Kaplan-Meier demonstrating cardiac mortality in patients clas-
ified according to early diastolic mitral annular velocity (Em) 3 or Em
3 cm/s. Cum  cumulative.
igure 2. Incremental value of early diastolic mitral annular velocity (Em)
3 and early diastolic transmitral flow velocity (E)/Em 15 in predicting
ong-term (median 48 months) cardiac mortality. The addition of decel-
ration time (DT), E/Em, and Em resulted in significant incremental
mprovements in the predictive value of a model including clinical risk
actors (age, ischemic heart disease, valvular heart disease, and heart
ailure): chi-square (2) 25.0 with five degrees of freedom for clinical risk
actors; chi-square  29.4 with one degree of freedom for clinical risk
actors plus DT 140 ms; chi-square  33.0 with one degree of freedom
or clinical risk factors plus DT 140 ms plus E/Em 15; and chi-square
37.3 with one degree of freedom for clinical risk factors plus DT 140
s plus E/Em 15 plus Em 3.tudy limitations. This cohort has a relatively high prev-
lence of patients suffering from hypertension (51%) with
pproximately equal prevalence of coronary artery disease
38%) and diabetes mellitus (35%). However, it represents a
onsecutive series of patients and may simply confirm our
revious data that hypertension was the most common
ssociated risk factor for congestive heart failure in Hong
ong (20) and that itself alone or in combination with
oronary artery disease was the most common condition
redating the onset of heart failure (21).
Our study end point was cardiac mortality including
udden death. It is assumed that this is due to a cardiac
rrhythmia, although this cannot be proved conclusively.
onclusions. The current data demonstrate that Em is a
owerful predictor of survival in patients with LV systolic
mpairment; Em 3 cm/s emerges as the best prognostica-
or in long-term follow-up, incremental to other clinical or
chocardiographic variables, including the E/Em. This
asily acquired diastolic index assists in stratifying cardio-
ascular risk in this group of patients.
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/F, Clinical Sciences Building, Division of Cardiology, Depart-
ent of Medicine and Therapeutics, The Chinese University
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